This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

TRADE NEWS: Agilent Technologies Oligo Design Tool Expanded To Include Custom CGH, ChIP-on-Chip, DNA Methylation Array Capabilities

Agilent Technologies Inc. (NYSE: A) today introduced an enhanced version of SureDesign software enabling clinical researchers to design customized CGH (comparative genomic hybridization), ChIP-on-chip (chromatin immunoprecipitation), and DNA methylation microarrays for molecular cytogenomics and other applications.

The new version of SureDesign replaces these microarray applications for the eArray platform and provides users with a more streamlined and intuitive design experience. Existing eArray user data has been automatically transferred to the new SureDesign software. Researchers will continue to receive the same unmatched flexibility in microarray design capabilities as before but with greater ease and at speeds up to five times faster.

“The new SureDesign platform is one of the best websites I’ve encountered for online design and molecular biology,” said Dr. Kenneth Beckman, director of the University of Minnesota’s Biomedical Genomics Center. “Transitioning from eArray has been a seamless process, and we are enjoying the remarkable power and flexibility of the platform’s enhanced design tools.”

SureDesign’s expanded design capabilities include a number of important features not available on any other platform:

  • SureDesign is the only publicly available microarray design platform in the industry.
  • The platform is free to all registered users.
  • Unmatched flexibility enables users to design using pre-existing content or from Agilent’s high-definition CGH and location analysis databases.
  • SureDesign has both “standard” and “advanced” design settings for easier navigation of routine designs, and it provides advanced users with more control to customize inputs if they choose.
  • Arrays are available in eight different formats. Researchers can simultaneously query up to six different genome databases while they individually customize the number of unique probes and level of redundancy they require.
  • SureDesign’s intuitive design environment enables researchers to input customizable parameters tailored to their specific needs, allowing more control over the potential for incidental findings.

“The new SureDesign platform resolves several considerable pain points for our molecular cytogenetic researchers,” said Victor Fung, senior director of marketing for Agilent’s Genomics division. “It not only optimizes the capabilities of our SurePrint technology, it delivers custom array content and designs that meet a full spectrum of research objectives while providing a rapid, flexible and economical alternative to off-the-shelf design platforms.”

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs